Brawn Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

10.21

11.17

5.41

3.21

17.13

Operating profit

-0.55

-0.16

-1.28

-0.72

-0.10

Interest

-

-

0.01

0.06

0.01

Gross profit

-0.55

-0.16

-1.38

-0.69

-0.11

EPS (Rs)

-1.98

-0.74

-3.12

-2.36

-0.44

Other income

-

-

-0.09

0.09

-

Stock adjustment

1.06

0.04

-3.42

-1.04

-0.09

Raw material

-

0.05

-

-

-

Power and fuel

-

-

-

-

-

Employee expenses

0.72

0.69

0.77

1.04

1.05

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

8.98

10.54

9.35

3.94

16.27

Provisions made

-

-

-

-

-

Depreciation

0.04

0.05

0.04

0.02

0.02

Taxation

-

0.01

-0.47

-

-

Net profit / loss

-0.60

-0.22

-0.94

-0.71

-0.13

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

3.00

3.00

3.00

3.00

3.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-5.38

-1.43

-23.65

-22.61

-0.57

GPM (%)

-5.39

-1.44

-25.82

-20.89

-.66

NPM (%)

-5.83

-2.00

-17.59

-21.45

-0.76